Language

Chinese English

Home page

CPIC 2026 | Protheragen Session: Cross-Border Transactions in Global Biopharmaceuticals

Apr 17,2026

The inaugural China Pharmaceutical Innovation Congress (CPIC) 2026, hosted by Tongxieyi, will be grandly held at the National Exhibition and Convention Center (Shanghai) from July 22 to 24, 2026.

Modeled after the J.P. Morgan Healthcare Conference in the United States, CPIC establishes an innovative paradigm: China Innovation – Global Translation – Shanghai Deal-Making. As the premier window for overseas capital and enterprises to gain insights into China’s innovation ecosystem, and the core hub for Chinese pharmaceutical companies to advance global expansion and connect with the world, the China Pharmaceutical Innovation Congress is poised to become the bellwether event for annual healthcare industry investment and collaboration. The congress will feature dozens of thematic sessions covering a wide range of high-profile topics and future directions in healthcare industry innovation, investment, and global development.

The global biopharmaceutical industry is undergoing profound restructuring, with cross-border transactions evolving from opportunity-driven to strategy-driven. How can Chinese innovative pharmaceutical companies position themselves in the global landscape? How can high-quality overseas assets accurately align with demand in the Chinese market?

Against this backdrop, the Special Session on Global Biopharmaceutical Cross-Border Transactions, co-hosted by Protheragen and Tongxieyi, will focus on core topics including License-in / License-out, cross-border M&A, and joint development. It will bring together frontline dealmakers in international transactions to share practical experience and cutting-edge insights. The session aims to build a pragmatic and efficient communication platform for participants, foster multi-party exchanges and in-depth cooperation, and jointly explore sustainable, high-quality pathways to global expansion.

Session Theme | Global Biopharmaceutical Cross‑Border Transactions

Hosts | Protheragen, Tongxieyi

Venue | Hall 4.2, National Exhibition and Convention Center (Shanghai)

About Protheragen

Headquartered in New York, Protheragen is a global biopharmaceutical strategic value advancement firm integrating scientific insights, business strategy, and legal compliance. With nearly 20 years of profound industry expertise, we serve not only as an observer of global pharmaceutical trends but also as a co-creator of deep value for innovative life science assets.

Leveraging our dual U.S.-China strategic hubs, Protheragen has built a full-chain empowerment system spanning incubation, capital enablement, and global pipeline restructuring. Our in-house scientific advisory team and laboratory resources deeply engage in global strategy design for early-stage projects. Through targeted strategic investments, we directly accelerate the R&D progress of high-potential pipelines. Furthermore, drawing on our precise understanding of the strategic trajectories of global industry leaders and strong alignment with top-tier industrial capital, we help partners establish their core value positioning in complex international contexts.

We are committed to eliminating cultural and transactional frictions in cross-border collaboration. For every viable innovative achievement, we craft a strategic roadmap to the global market, elevating the stature and influence of China’s pharmaceutical innovation on the world stage.

About TONACEA

TONACEA is a premier ecosystem platform in China's biomedical innovation sector. With over 20 years of deep engagement in China's innovative drug development, it has grown into a key organizational force driving China's pharmaceutical innovation and serves as a core hub connecting multinational pharmaceutical companies with local innovation.

TONACEA brings together multinational pharmaceutical companies, biotech firms, investment institutions, research institutes, and regulatory experts, establishing a high-end professional network and knowledge-sharing system that covers the entire R&D value chain. Its business encompasses industry summits, technical forums, customized corporate training, media communications, and strategic consulting. With multiple branches across China, TONACEA has built an operational network that extends nationwide. Its official WeChat account and video channel consistently deliver in-depth industry insights, with perspectives frequently cited by investors and media, earning recognition as a trusted authoritative source within the industry.

Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
The overseas registration link will be available soon. Stay tuned!

Prev: CPIC 2026 | The Chinese General Chamber of Commerce in Hong Kong and Hong Kong Biomedical Innovation Association Join Forces to Open a New Chapter for China’s National Pharmaceutical Power

Next: Blockbuster Deals Resurge in ADC Space

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Public Account QR Code

Registration QR Code

Conference Service Hotline

+86 10 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.